Gene therapy approaches to regenerating the musculoskeletal system

Injuries to the musculoskeletal system are common, debilitating and expensive. In many cases, healing is imperfect, which leads to chronic impairment. Gene transfer might improve repair and regeneration at sites of injury by enabling the local, sustained and potentially regulated expression of therapeutic gene products; such products include morphogens, growth factors and anti-inflammatory agents. Proteins produced endogenously as a result of gene transfer are nascent molecules that have undergone post-translational modification. In addition, gene transfer offers particular advantages for the delivery of products with an intracellular site of action, such as transcription factors and noncoding RNAs, and proteins that need to be inserted into a cell compartment, such as a membrane. Transgenes can be delivered by viral or nonviral vectors via in vivo or ex vivo protocols using progenitor or differentiated cells. The first gene transfer clinical trials for osteoarthritis and cartilage repair have already been completed. Various bone-healing protocols are at an advanced stage of development, including studies with large animals that could lead to human trials. Other applications in the repair and regeneration of skeletal muscle, intervertebral disc, meniscus, ligament and tendon are in preclinical development. In addition to scientific, medical and safety considerations, clinical translation is constrained by social, financial and logistical issues.

[1]  J. Hoyland,et al.  Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. , 2009, European cells & materials.

[2]  F. Michetti,et al.  Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models , 2008, Gene Therapy.

[3]  W. Zhou,et al.  Angiogenic gene‐modified myoblasts promote vascularization during repair of skeletal muscle defects , 2015, Journal of tissue engineering and regenerative medicine.

[4]  H. Drissi,et al.  Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair , 2013, Gene Therapy.

[5]  James D. Kang,et al.  Potential applications of gene therapy to the treatment of intervertebral disc disorders. , 2000, Clinical orthopaedics and related research.

[6]  P. Robbins,et al.  Osteoarthritis gene therapy , 2004, Gene Therapy.

[7]  F. Jakob,et al.  BMP12 and BMP13 gene transfer induce ligamentogenic differentiation in mesenchymal progenitor and anterior cruciate ligament cells. , 2010, Cytotherapy.

[8]  Freddie H. Fu,et al.  Gene transfer to the tendon-bone insertion site , 2004, Knee Surgery, Sports Traumatology, Arthroscopy.

[9]  F. Gao,et al.  Lentivirus-mediated Wnt10b overexpression enhances fracture healing in a rat atrophic non-union model , 2014, Biotechnology Letters.

[10]  C. Ha,et al.  Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients , 2012, Cytotherapy.

[11]  Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair , 2012, Cell and Tissue Research.

[12]  K. Lau,et al.  Lentiviral‐based BMP4 in vivo gene transfer strategy increases pull‐out tensile strength without an improvement in the osteointegration of the tendon graft in a rat model of biceps tenodesis , 2011, The journal of gene medicine.

[13]  M. Göken,et al.  Cell-based resurfacing of large cartilage defects: long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis. , 2008, Arthritis and rheumatism.

[14]  Jo Wixon,et al.  Gene therapy clinical trials worldwide to 2012 – an update , 2013, The journal of gene medicine.

[15]  Wenzhong Li,et al.  Non-viral gene delivery methods. , 2013, Current pharmaceutical biotechnology.

[16]  Freddie H. Fu,et al.  Enhancement of Tendon-Bone Integration of Anterior Cruciate Ligament Grafts with Bone Morphogenetic Protein-2 Gene Transfer: A Histological and Biomechanical Study , 2002, The Journal of bone and joint surgery. American volume.

[17]  L. Begum,et al.  Implantation of rAAV5-IGF-I transduced autologous chondrocytes improves cartilage repair in full-thickness defects in the equine model. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  R. Porter,et al.  Ex vivo adenoviral transfer of bone morphogenetic protein 12 (BMP-12) cDNA improves Achilles tendon healing in a rat model , 2008, Gene Therapy.

[19]  M. Bouxsein,et al.  Direct percutaneous gene delivery to enhance healing of segmental bone defects. , 2006, The Journal of bone and joint surgery. American volume.

[20]  野崎 正浩 Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth , 2009 .

[21]  Piyush Koria,et al.  Delivery of Growth Factors for Tissue Regeneration and Wound Healing , 2012, BioDrugs.

[22]  K. Xin,et al.  Adeno-associated virus-2-mediated bFGF gene transfer to digital flexor tendons significantly increases healing strength. an in vivo study. , 2008, The Journal of bone and joint surgery. American volume.

[23]  P. Robbins,et al.  Dual transduction of insulin‐like growth factor‐I and interleukin‐l receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  J. Affeldt,et al.  The feasibility study , 2019, The Information System Consultant’s Handbook.

[25]  S. Goldstein,et al.  Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Archer,et al.  Enhanced Adenovirus Transduction of hMSCs Using 3D Hydrogel Cell Carriers , 2013, Molecular Biotechnology.

[27]  F. O'Brien,et al.  The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[28]  J. Li,et al.  Adenoviral‐mediated transfer of human BMP‐6 gene accelerates healing in a rabbit ulnar osteotomy model , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[29]  P. Robbins,et al.  Direct adenovirus-mediated insulin-like growth factor I gene transfer enhances transplant chondrocyte function. , 2001, Human gene therapy.

[30]  Freddie H. Fu,et al.  The timing of administration of a clinically relevant dose of losartan influences the healing process after contusion induced muscle injury. , 2013, Journal of applied physiology.

[31]  H. Madry,et al.  Overexpression of human IGF-I via direct rAAV-mediated gene transfer improves the early repair of articular cartilage defects in vivo , 2014, Gene Therapy.

[32]  J. Schertzer,et al.  Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury , 2006, Gene Therapy.

[33]  Freddie H. Fu,et al.  Transfer of lacZ marker gene to the meniscus. , 1999, The Journal of bone and joint surgery. American volume.

[34]  S. Gambhir,et al.  "Same day" ex-vivo regional gene therapy: a novel strategy to enhance bone repair. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  Dong Han,et al.  Repair of bone defect by using vascular bundle implantation combined with Runx II gene-transfected adipose-derived stem cells and a biodegradable matrix , 2013, Cell and Tissue Research.

[36]  R. Guldberg,et al.  Biological effects of rAAV-caAlk2 coating on structural allograft healing. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  Xin Fu,et al.  Adenovirus-mediated transfer of siRNA against Runx2/Cbfa1 inhibits the formation of heterotopic ossification in animal model. , 2006, Biochemical and biophysical research communications.

[38]  Freddie H. Fu,et al.  Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. , 2009, Arthritis and rheumatism.

[39]  Christian Lattermann,et al.  A gene therapy approach to accelerating bone healing Evaluation of gene expression in a New Zealand white rabbit model , 1999, Knee Surgery, Sports Traumatology, Arthroscopy.

[40]  J. Lou,et al.  Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[41]  P. Robbins,et al.  Genetically augmented tissue engineering of the musculoskeletal system. , 1999, Clinical orthopaedics and related research.

[42]  F. Ambrosio,et al.  Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[43]  K. Swan,et al.  Raoul Hoffmann and his external fixator. , 2007, The Journal of bone and joint surgery. American volume.

[44]  P. Robbins,et al.  Arthritis gene therapy and its tortuous path into the clinic. , 2013, Translational research : the journal of laboratory and clinical medicine.

[45]  M. Bouxsein,et al.  Healing of segmental bone defects by direct percutaneous gene delivery: effect of vector dose. , 2007, Human gene therapy.

[46]  J. West,et al.  Rapid healing of femoral defects in rats with low dose sustained BMP2 expression from PEGDA hydrogel microspheres , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[47]  Adam Bagg,et al.  Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. , 2003, Molecular genetics and metabolism.

[48]  Antonios G Mikos,et al.  Osteochondral tissue regeneration through polymeric delivery of DNA encoding for the SOX trio and RUNX2. , 2014, Acta biomaterialia.

[49]  R. Warren,et al.  Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein‐7 , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[50]  P. Leng,et al.  Enhanced Meniscal Repair by Overexpression of hIGF-1 in a Full-thickness Model , 2009, Clinical orthopaedics and related research.

[51]  P. Robbins,et al.  Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway , 2002, Gene Therapy.

[52]  Xin Zhang,et al.  Targeted delivery of non-viral vectors to cartilage in vivo using a chondrocyte-homing peptide identified by phage display. , 2011, Biomaterials.

[53]  Johnny Huard,et al.  Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. , 2002, The Journal of clinical investigation.

[54]  Toby King,et al.  The burden of musculoskeletal diseases in the United States. , 2016, Seminars in arthritis and rheumatism.

[55]  Matthew J. Silva,et al.  BMP‐12 gene transfer augmentation of lacerated tendon repair , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[56]  C. Evans Gene therapy for the regeneration of bone. , 2011, Injury.

[57]  P. Beredjiklian,et al.  Effect of interleukin-10 overexpression on the properties of healing tendon in a murine patellar tendon model. , 2008, The Journal of hand surgery.

[58]  P. Bourgine,et al.  Engineering of a functional bone organ through endochondral ossification , 2013, Proceedings of the National Academy of Sciences.

[59]  P. S. Rachakonda,et al.  Application of inflammation-responsive promoter for an in vitro arthritis model. , 2008, Arthritis and rheumatism.

[60]  T Ochi,et al.  Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament , 1998, Gene Therapy.

[61]  A. Mikos,et al.  Strategies for controlled delivery of biologics for cartilage repair. , 2015, Advanced drug delivery reviews.

[62]  C. Pilapil,et al.  Genetically enhanced engineering of meniscus tissue using ex vivo delivery of transforming growth factor-beta 1 complementary deoxyribonucleic acid. , 2007, Tissue engineering.

[63]  A J Nixon,et al.  Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. , 2007, The Journal of bone and joint surgery. British volume.

[64]  H. Madry,et al.  Direct rAAV SOX9 administration for durable articular cartilage repair with delayed terminal differentiation and hypertrophy in vivo , 2012, Journal of Molecular Medicine.

[65]  Mark Vrahas,et al.  Facilitated endogenous repair: making tissue engineering simple, practical, and economical. , 2007, Tissue engineering.

[66]  Freddie H. Fu,et al.  Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. , 2013, The Journal of bone and joint surgery. American volume.

[67]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[68]  F. Ambrosio,et al.  Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. , 2007, The Journal of biological chemistry.

[69]  M. Knopp,et al.  Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model. , 2011, Osteoarthritis and cartilage.

[70]  Yubo Fan,et al.  A histological and biomechanical study of bone stress and bone remodeling around immediately loaded implants , 2014, Science China Life Sciences.

[71]  Lawrence V. Gulotta,et al.  Bone Marrow–Derived Mesenchymal Stem Cells Transduced With Scleraxis Improve Rotator Cuff Healing in a Rat Model , 2011, The American journal of sports medicine.

[72]  Freddie H. Fu,et al.  Development of approaches to improve the healing following muscle contusion. , 1998, Cell transplantation.

[73]  L. Jeng,et al.  LARGE‐SCALE BICORTICAL SKULL BONE REGENERATION USING EX VIVO REPLICATION‐DEFECTIVE ADENOVIRAL‐MEDIATED BONE MORPHOGENETIC PROTEIN—2 GENE—TRANSFERRED BONE MARROW STROMAL CELLS AND COMPOSITE BIOMATERIALS , 2009, Neurosurgery.

[74]  V. Rosen,et al.  Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. , 1997, The Journal of clinical investigation.

[75]  K. Lau,et al.  Retroviral‐based gene therapy with cyclooxygenase‐2 promotes the union of bony callus tissues and accelerates fracture healing in the rat , 2008, The journal of gene medicine.

[76]  M. Ferretti,et al.  Adeno-associated viral gene transfer of transforming growth factor-β1 to human mesenchymal stem cells improves cartilage repair , 2007, Gene Therapy.

[77]  E Schneider,et al.  Effect of BMP-2 gene transfer on bone healing in sheep , 2006, Gene Therapy.

[78]  Tarun Garg,et al.  Scaffold: a novel carrier for cell and drug delivery. , 2012, Critical reviews in therapeutic drug carrier systems.

[79]  Lian Zhu,et al.  Enhanced healing of goat femur‐defect using BMP7 gene‐modified BMSCs and load‐bearing tissue‐engineered bone , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[80]  M. Alini,et al.  Barriers and strategies for the clinical translation of advanced orthopaedic tissue engineering protocols. , 2014, European cells & materials.

[81]  E Schneider,et al.  Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. , 2006, Human gene therapy.

[82]  C. Evans Advances in regenerative orthopedics. , 2013, Mayo Clinic proceedings.

[83]  D. Docheva,et al.  Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by ectopic expression of scleraxis. , 2012, Stem cells and development.

[84]  T Minas,et al.  A primer in cartilage repair. , 2012, The Journal of bone and joint surgery. British volume.

[85]  James D Kang,et al.  Gene therapy for intervertebral disk degeneration. , 2011, The Orthopedic clinics of North America.

[86]  Jonathan M. Brunger,et al.  Tissue-engineered cartilage with inducible and tunable immunomodulatory properties. , 2014, Biomaterials.

[87]  Yan Jin,et al.  The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a. , 2013, Biomaterials.

[88]  Lin Lin,et al.  Effects of transforming growth factor-β1 and vascular endothelial growth factor 165 gene transfer on Achilles tendon healing , 2009 .

[89]  Hiromu Ito,et al.  Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy , 2005, Nature Medicine.

[90]  D. Zurakowski,et al.  Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[91]  Johnny Huard,et al.  The Use of an Antifibrosis Agent to Improve Muscle Recovery after Laceration * , 2001, The American journal of sports medicine.

[92]  Marjolein C H van der Meulen,et al.  Mesenchymal stem cells and insulin‐like growth factor‐I gene‐enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[93]  M. Bouxsein,et al.  Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects , 2007, Gene Therapy.

[94]  J. Lieberman,et al.  Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. , 2008, Bone.

[95]  Martin Majewski,et al.  Biologics for tendon repair , 2014, Advanced drug delivery reviews.

[96]  C. Evans Using genes to facilitate the endogenous repair and regeneration of orthopaedic tissues , 2014, International Orthopaedics.

[97]  Jonathan M. Brunger,et al.  Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage , 2014, Proceedings of the National Academy of Sciences.

[98]  E. Chang,et al.  SEIZURE CHARACTERISTICS AND CONTROL AFTER MICROSURGICAL RESECTION OF SUPRATENTORIAL CEREBRAL CAVERNOUS MALFORMATIONS , 2009, Neurosurgery.

[99]  Lawrence V. Gulotta,et al.  Adenoviral-Mediated Gene Transfer of Human Bone Morphogenetic Protein–13 Does Not Improve Rotator Cuff Healing in a Rat Model , 2011, The American journal of sports medicine.

[100]  L. Zekas,et al.  Dermal fibroblast‐mediated BMP2 therapy to accelerate bone healing in an equine osteotomy model , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[101]  M. Kunz,et al.  Direct bone morphogenetic protein 2 and Indian hedgehog gene transfer for articular cartilage repair using bone marrow coagulates. , 2015, Osteoarthritis and cartilage.

[102]  A. Mikos,et al.  Gene delivery strategies for cartilage tissue engineering. , 2006, Advanced drug delivery reviews.

[103]  James M. Wilson,et al.  Humoral Immune Response to AAV , 2013, Front. Immunol..

[104]  D. Stewart,et al.  Effect of cell‐based VEGF gene therapy on healing of a segmental bone defect , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[105]  W. Hauswirth,et al.  scAAV-Mediated Gene Transfer of Interleukin 1-Receptor Antagonist to Synovium and Articular Cartilage in Large Mammalian Joints , 2012, Gene Therapy.

[106]  Yong Li,et al.  Angiotensin II Receptor Blockade Administered after Injury Improves Muscle Regeneration and Decreases Fibrosis in Normal Skeletal Muscle , 2008, The American journal of sports medicine.

[107]  Gil Navon,et al.  Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. , 2006, The Journal of clinical investigation.

[108]  P. Aspenberg,et al.  Mechanical Load and BMP Signaling During Tendon Repair: A Role for Follistatin? , 2008, Clinical orthopaedics and related research.

[109]  C. Herzog,et al.  [Interleukin 1 and tumor necrosis factor]. , 1987, Zeitschrift fur Rheumatologie.

[110]  Juan Li,et al.  Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[111]  Johnny Huard,et al.  BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[112]  S. Ghivizzani,et al.  Orthopedic gene therapy—lost in translation? , 2012, Journal of cellular physiology.

[113]  J. Huard,et al.  Regenerative medicine for the musculoskeletal system based on muscle-derived stem cells. , 2008, The Journal of the American Academy of Orthopaedic Surgeons.

[114]  E. Schwarz,et al.  Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[115]  H. Madry,et al.  Nonviral gene transfer to human meniscal cells. Part I: transfection analyses and cell transplantation to meniscus explants , 2014, International Orthopaedics.

[116]  P. Robbins,et al.  Getting arthritis gene therapy into the clinic , 2011, Nature Reviews Rheumatology.

[117]  M. Spector,et al.  Gene delivery to cartilage defects using coagulated bone marrow aspirate , 2004, Gene Therapy.

[118]  C. Yu,et al.  Non-virus-mediated transfer of siRNAs against Runx2 and Smad4 inhibit heterotopic ossification in rats , 2010, Gene Therapy.

[119]  Freddie H. Fu,et al.  Biological approaches to improve skeletal muscle healing after injury and disease. , 2012, Birth defects research. Part C, Embryo today : reviews.

[120]  A. Montag,et al.  BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury. , 2007, The Journal of bone and joint surgery. American volume.

[121]  Yong Li,et al.  Gamma interferon as an antifibrosis agent in skeletal muscle , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[122]  W. Dhert,et al.  Non-viral gene therapy for bone tissue engineering , 2013, Biotechnology & genetic engineering reviews.

[123]  J. Huard,et al.  The Use of Relaxin Improves Healing in Injured Muscle , 2005, Annals of the New York Academy of Sciences.

[124]  C. Evans,et al.  Potential biologic therapies for the intervertebral disc. , 2006, The Journal of bone and joint surgery. American volume.

[125]  J. Rasko,et al.  Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response , 2006, Nature Medicine.

[126]  P. Robbins,et al.  Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. , 1997, Osteoarthritis and cartilage.

[127]  R Krauspe,et al.  Potential role of direct adenoviral gene transfer in enhancing fracture repair. , 2000, Clinical orthopaedics and related research.

[128]  D. Zurakowski,et al.  Transplanted articular chondrocytes co-overexpressing IGF-I and FGF-2 stimulate cartilage repair in vivo , 2011, Knee Surgery, Sports Traumatology, Arthroscopy.

[129]  C. Hidaka,et al.  Evaluation of direct in vivo gene transfer in an equine metacarpal IV ostectomy model using an adenoviral vector encoding the bone morphogenetic protein-2 and protein-7 gene. , 2012, Veterinary surgery : VS.

[130]  C. Dani,et al.  Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[131]  D. Matičić,et al.  Articular cartilage repair by genetically modified bone marrow aspirate in sheep , 2011, Gene Therapy.

[132]  Kjeld Søballe,et al.  Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[133]  D. Kohn,et al.  rAAV-mediated overexpression of FGF-2 promotes cell proliferation, survival, and α-SMA expression in human meniscal lesions , 2009, Gene Therapy.